COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 05 2023
25 05 2023
Historique:
received:
26
05
2022
accepted:
26
04
2023
medline:
29
5
2023
pubmed:
26
5
2023
entrez:
25
5
2023
Statut:
epublish
Résumé
The physiological effects of vaccination against SARS-CoV-2 (COVID-19) are well documented, yet the behavioural effects not well known. Risk compensation suggests that gains in personal safety, as a result of vaccination, are offset by increases in risky behaviour, such as socialising, commuting and working outside the home. This is potentially important because transmission of SARS-CoV-2 is driven by contacts, which could be amplified by vaccine-related risk compensation. Here, we show that behaviours were overall unrelated to personal vaccination, but-adjusting for variation in mitigation policies-were responsive to the level of vaccination in the wider population: individuals in the UK were risk compensating when rates of vaccination were rising. This effect was observed across four nations of the UK, each of which varied policies autonomously.
Identifiants
pubmed: 37231004
doi: 10.1038/s41598-023-34244-2
pii: 10.1038/s41598-023-34244-2
pmc: PMC10209557
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8441Subventions
Organisme : Department of Health
ID : NIHR200915
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12023/22
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110110/Z/15/Z
Pays : United Kingdom
Investigateurs
Tina Thomas
(T)
Daniel Ayoubkhani
(D)
Russell Black
(R)
Antonio Felton
(A)
Megan Crees
(M)
Joel Jones
(J)
Lina Lloyd
(L)
Esther Sutherland
(E)
Emma Pritchard
(E)
Karina-Doris Vihta
(KD)
George Doherty
(G)
James Kavanagh
(J)
Kevin K Chau
(KK)
Stephanie B Hatch
(SB)
Daniel Ebner
(D)
Lucas Martins Ferreira
(LM)
Thomas Christott
(T)
Wanwisa Dejnirattisai
(W)
Juthathip Mongkolsapaya
(J)
Sarah Cameron
(S)
Phoebe Tamblin-Hopper
(P)
Magda Wolna
(M)
Rachael Brown
(R)
Richard Cornall
(R)
Gavin Screaton
(G)
Stuart Cox
(S)
Kevin Paddon
(K)
Tim James
(T)
Thomas House
(T)
Julie Robotham
(J)
Paul Birrell
(P)
Helena Jordan
(H)
Tim Sheppard
(T)
Graham Athey
(G)
Dan Moody
(D)
Leigh Curry
(L)
Pamela Brereton
(P)
Ian Jarvis
(I)
Anna Godsmark
(A)
George Morris
(G)
Bobby Mallick
(B)
Phil Eeles
(P)
Jodie Hay
(J)
Harper VanSteenhouse
(H)
Jessica Lee
(J)
Sean White
(S)
Tim Evans
(T)
Lisa Bloemberg
(L)
Katie Allison
(K)
Anouska Pandya
(A)
Sophie Davis
(S)
David I Conway
(DI)
Margaret MacLeod
(M)
Chris Cunningham
(C)
Katrina Lythgoe
(K)
David Bonsall
(D)
Tanya Golubchik
(T)
Helen Fryer
(H)
Informations de copyright
© 2023. The Author(s).
Références
Lancet. 2021 Jun 26;397(10293):2461-2462
pubmed: 34139198
Lancet Public Health. 2021 Jan;6(1):e30-e38
pubmed: 33308423
J Epidemiol Community Health. 2022 Feb;76(2):109-115
pubmed: 34244309
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2022 Feb 3;386(5):494-496
pubmed: 34965358
Clin Infect Dis. 2018 Aug 16;67(5):676-686
pubmed: 29509889
Nat Med. 2021 Dec;27(12):2127-2135
pubmed: 34650248
Hum Vaccin Immunother. 2016 Jun 2;12(6):1435-50
pubmed: 26864126
JAMA Netw Open. 2021 Oct 1;4(10):e2131137
pubmed: 34698850
BMJ. 2021 May 13;373:n1088
pubmed: 33985964
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Nat Med. 2021 Sep;27(9):1614-1621
pubmed: 34244681
MMWR Morb Mortal Wkly Rep. 2021 Apr 02;70(13):495-500
pubmed: 33793460
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
BMJ. 2021 Aug 20;374:n1943
pubmed: 34417165
PeerJ. 2019 May 27;7:e6876
pubmed: 31179172
BMJ. 2006 Mar 11;332(7541):605-7
pubmed: 16528088
Curr Med Res Opin. 2022 Dec;38(12):2021-2028
pubmed: 36106710
Ann Intern Med. 2021 Jun;174(6):858-859
pubmed: 33646837
BMJ. 2020 Jul 26;370:m2913
pubmed: 32713835
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274